Risultati della ricerca - Ya Wan
- Mostra 1 - 3 risultati su 3
-
1
Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors Autoría: Tian Yu, Xiangyu Liu, Chi‐Yuan Wu, Zhiyu Tang, Hongwei Wang, Patrick Schnell, Ya Wan, Kun Wang, Lucy Liu, Yuying Gao, Srikumar Sahasranaman, Nageshwar Budha
Pubblicazione 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model‐Based Approach Autoría: Ahsan Rizwan, Hugh Giovinazzo, Tian Yu, Yuying Gao, Kun Wang, Fengyan Xu, Ya Wan, Jun Wang, Srikumar Sahasranaman, Marcia Campbell, Patrick Schnell, Ramil Abdrashitov, William D. Hanley, Nageshwar Budha
Pubblicazione 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial Impact Autoría: Tian Yu, Chi‐Yuan Wu, Srikumar Sahasranaman, Xianbin Tian, Ying Fei Li, Zhiyu Tang, Yanfei Yang, Ya Wan, Quting Zhang, Patrick Schnell, Ariadna Mendoza‐Naranjo, Ramil Abdrashitov, William D. Hanley, Nageshwar Budha
Pubblicazione 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso